Latest News about companies
Recent news which mentions companies
FDA approves Merck's drug for rare, deadly lung condition
March 26, 2024
From CNBC.com News
Moderna says new Covid vaccine showed stronger immune response than current shot in study
March 26, 2024
From CNBC.com News
From CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
March 24, 2024
From CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
March 23, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Saudi Arabia's massive wealth fund is in talks to acquire national airline Saudia: Report
March 18, 2024
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
March 14, 2024
From CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
March 13, 2024
From CNBC.com News
From CNBC.com News
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
March 10, 2024
From CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
March 08, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Biden says Medicare should negotiate prices for at least 50 drugs each year, up from a target of 20
March 06, 2024
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
British telco giant BT expects to launch 5G standalone — or 'true' 5G — later this year
March 01, 2024
From CNBC.com News
Here's what tech giants are betting on next — from robot dogs to smartphones you can wear on your wrist
February 29, 2024
From CNBC.com News
From CNBC.com News
Novavax misses quarterly estimates, but vaccine maker narrows losses as it slashes costs
February 28, 2024
From CNBC.com News
From CNBC.com News
Bank CEO shrugs off U.S. war on 'woke' capital, says ESG investing is good for business
February 27, 2024
From CNBC.com News
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
